The Manchester Cancer Research centre is a hub of scientific innovation in research, driving decades of practice-influencing cancer care. One of the mainstays of the innovative approaches employed is Team Science, where scientists, clinicians and patients come together in joint sessions. These sessions lead to new research ideas within scientific “Town Halls”.
But despite the increasingly sophisticated technologies available for the diagnosis and treatment of cancer, a crucial factor is still being ignored: patient complexity. This omission is leading to unrepresentative research in the lab and inappropriate design of clinical trials. What can be done to fix this?
Led by Robert Bristow, Cancer Research UK’s unique mission in Manchester is to provide “Precision Cancer Medicine for All”. This approach contrasts to studies that are highly selective of patients from Eurocentric backgrounds and/or may be relatively healthy.
The Manchester research centre also recognises the importance of addressing the needs of medically and socially complex patients, many of whom are currently excluded from UK and global precision oncology trials. Manchester has numerous underserved populations secondary to socioeconomic hardship who have multiple health problems.
As patients age, other non-cancer health conditions invariably develop with new medications used for their diabetes, cardiovascular disease, and arthritis. These factors can affect therapy side effects and treatment success, including a patient’s response to immunotherapy.
Manchester’s approach is to recognise and work within the diverse populations in Greater Manchester and in so doing, ensure the research is equitable, diverse, and inclusive (EDI). With an EDI lens, specific exemplars will be presented that use scientific and public engagement across these populations for the design of new clinical trials. This will exploit opportunities to drive innovative care changes that will impact our patients in the UK and worldwide.
Join us to find out more about the innovative methods employed by Manchester Cancer Research from Robert Bristow, a multi-award-winning Research Scientist and Scientific Advisor.